ESTUDIOS ABIERTOS
Cáncer de Endometrio
ENGOT EN-09LEAP-001 / GEICO 83-E (MJ Rubio)
A Phase 3 Randomized, Open-Label, Trial of Pembrolizumab Plus Lenvatinib Versus Chemotherapy for the First-line Treatment of Persistent, Recurrent or Metastatic Endometrial Carcinoma.
GEICO 75-E/ATTEND (P Barretina)
Phase III randomized placebo-controlled trial of atezolizumab in combination with paclitaxel and carboplatin in women with advanced/recurrent endometrial cancer.
ENGOT EN5/GEICO 67-E/SIENDO (A Pérez Fidalgo)
A Phase III Trial of Maintenance with Selinexor/ Placebo After Combination Chemotherapy for Patients with Advanced or Recurrent Endometrial Cancer.
Estudio Avelumab WI 231461 AVE-IIG-03/GEICO 70-E (B Pardo)
A phase II trial of Avelumab in combination with pegylated liposomal doxorubicin in recurrent/metastatic endometrial cancer.
